FdaApplication
BLA 125523
Identifiers
- fda_app_no: BLA125523
Properties
| Property | Value |
|---|---|
| applicant_name | Mallinckrodt Pharma IP Trading DAC |
| application_type | BLA |
| approval_date | 2015-04-30 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RAPLIXA | — | 1G | Powder |
| RAPLIXA | — | 0.5G | Powder |
| RAPLIXA | — | 2G | Powder |
3 products